Lumaire Labs

Lumaire Labs is a biotechnology company focused on the development of Targeted Photobiomodulation (tPBM) therapies to address mitochondrial dysfunction and age-related diseases. The company's platform utilizes specific wavelengths of light to stimulate cytochrome c oxidase, thereby enhancing ATP production and reducing oxidative stress at the cellular level. Lumaire's primary therapeutic pipeline targets neurodegenerative disorders like Alzheimer's disease, alongside applications in ophthalmology and regenerative aesthetics. By combining physics and biology, the firm aims to provide non-invasive, systemic solutions for conditions currently lacking effective treatments. Lumaire Labs is positioned within the longevity biotechnology sector, emphasizing the restoration of cellular vitality as a means to extend healthy human lifespan.